Revolutionary treatment for high-risk, early-stage melanoma sees surging survival rates

A revolution in the treatment of high-risk, early-stage melanoma has been reached, with clinical trial results seeing surging survival rates.

Doctors are confident the new therapy approach, which will be subsidised by the Pharmaceutical Benefits Scheme (PBS), will overhaul the treatment of many types of deadly cancers.

A tumour the size of a golf ball saw death come knocking for Matthew Croxford.